Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program

Keywords

Medicine, Surveillance, Epidemiology, and End Results, Relative survival, Epidemiology, Oncology

References

• Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma최종원 — 2005
• Gender differences in non-small cell lung cancer: a population-based study.Adele Caldarella, Emanuele Crocetti, Camilla Comin — 2007
• International Classification of Diseases for OncologyP. A. Trott — 1977
• Completeness of hospital cancer case reporting from the SEER program of the national cancer instituteCalvin Zippin, Diana Lum, Benjamin F. Hankey — 1995
• Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer HistologiesSai‐Hong Ignatius Ou, Jason A. Zell — 2009
• Lung Cancer in Patients under 50 Years OldKeigo Tominaga, Kiyoshi Mori, Kohei Yokoi — 1999
• Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking StatusSai‐Hong Ignatius Ou, Argyrios Ziogas, Jason A. Zell — 2009
• Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma.Marc de Perrot, Marc Licker, Christine Bouchardy — 2000
• The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature ReviewFred R. Hirsch, Anna Spreafico, Silvia Novello — 2008
• Emerging ethnic differences in lung cancer therapyIkuo Sekine, Noboru Yamamoto, Kazuto Nishio — 2008
• Ethnic Disparities in Conditional Survival of Patients with Non-small Cell Lung CancerSamuel J. Wang, Clifton D. Fuller, Charles R. Thomas — 2007
• Lung cancer in never smokers--a review.S. Couraud, Gérard Zalcman, B. Milleron — 2012
• Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.A. Visbal, Brent A. Williams, Francis C. Nichols — 2004
• Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database.Jennifer B. Fu, T. Kau, Richard K. Severson — 2005
• Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.Robert J. Cerfolio, Ayesha S. Bryant, E. W. Scott — 2006
• Non-small-cell lung cancer: should histology guide chemotherapy treatment?Jaafar Bennouna, Hélène Senellart, Jean‐Yves Douillard — 2009
• Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.Scott D. Ramsey, Nadia Howlader, Ruth Etzioni — 2004
• Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.R. William Field, Bruce A. Smith, C. E. Platz — 2004
• Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.Shirish M. Gadgeel, Richard K. Severson, Ying Kau — 2001
• Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases.Elżbieta Radzikowska, Piotr Głaz, Krzysztof Roszkowski — 2002

Cited by

• Social Pathogenic Sources of Poor Community HealthHayden P. Smith — 2008
• Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis.Huafeng Shen, Seth Lipka, Ambuj Kumar — 2014
• Cost-Effectiveness of Hormone Therapy in the United StatesIngrid Lekander, Fredrik Borgström, O. Ström — 2009
• Cancer statistics, 2011Дмитрий Михайлович Рыжов — 2011
• Drug repurposing towards targeting cancer stem cells in pediatric brain tumors李莉蓓, 寇琦, 戚旭 — 2020
• African American Women's Personal Influencing Factors Associated with Pap Smear Testing and Cervical Cancer.Kelly Ackerson — 2008
• Detektion von KRAS-Gen-Mutationen beim BronchialkarzinomBettina Ostermayer — 2015
• 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.Mee‐Young Ahn, Taehyung Kim, Seong‐Min Kwon — 2015
• Preferences for Cancer Support Group Topics and Group Satisfaction Among Patients and CaregiversKathleen D. Morse, Richard J. Gralla, Judy A. Petersen — 2014
• COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common linkSteven Bozinovski, Ross Vlahos, Desiree Anthony — 2016
• Persuasive health communication : A self-perspectiveSuzanne Pietersma — 2009
• Creation of an Iron Oxide Core/Gold Shell Nanoparticle for Targeting Pancreatic CancerLisa Jacob — 2012
• Stereotactic radiosurgery and stereotactic radiotherapy for brain metastasesJasonK Rockhill, Lia M. Halasz — 2013
• Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China.T. Colin Campbell, Junshi Chen, C B Liu — 1990
• Improved survival for fallopian tube cancerStephanie L. Wethington, Thomas J. Herzog, Venkatraman Seshan — 2008
• Direct-to-consumer genetic testing: A survey of consumer perceptionsAlbert Blankley — 2013
• The National Children's Study of environmental effects on child health and development.Amy M. Branum, Gwen W. Collman, Adolfo Correa — 2003
• Overview of surgery for oral cavity cancer in OntarioAntoine Eskander, Jonathan C. Irish, Patrick Gullane — 2016
• Comparative effectiveness of three platinum‐doublet chemotherapy regimens in elderly patients with advanced non–small cell lung cancerJunya Zhu, Dhruv Sharma, Aileen B. Chen — 2013
• Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic reviewEric Chak, Sammy Saab — 2010

Related papers

• Comparison of Survival Rates for Abdominal Aortic Aneurysm Treatment MethodsIrene Hinterseher, H D Kuffner, Rainer Koch — 2012
• Improved survival in both histologic types of oesophageal cancer in SwedenMartin Sundelöf, Weimin Ye, Paul W. Dickman — 2002
• Survival of women with breast cancer in France: variation with age, stage and treatmentPascale Grosclaude, Marc Colonna, Guy Hédelin — 2001
• Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program.Lynn A. G. Ries, Marsha E. Reichman, Denise Riedel Lewis — 2003
• Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysis.Joseph M. Pepek, Peter A.S. Johnstone, Ashesh B. Jani — 2009
• Conditional Survival of All Primary Brain Tumor Patients by Age, Behavior, and HistologyKimberly R. Porter, Bridget J. McCarthy, Michael L. Berbaum — 2011
• PART III RESULT OF TREATMENTS COMPUTATION OF RELATIVE SURVIVAL RATESiduey J Cutler — 2000
• Management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. Surveillance, Epidemiology and End Results.Groome Pa, Mackillop Wj, Rothwell Dm — 2000
• Survival In Adult Acute Lymphoblastic Leukemia Survival By Age, Gender and EthnicityKrishna Bilas Ghimire, Binay Kumar Shah — 2013
• Trends in 5-year Relative Survival Rates for Intrahepatic Cholangiocarcinoma in the US: 13Vicky Bhagat, Diana Wu — 2016